Seeks Action on CBD, NAC other Nutritional Supplement Issues
WASHINGTON – The Natural Products Association (NPA) today congratulated Dr. Robert Califf on his Senate confirmation to be the next Commissioner of the FDA and said it looked forward to working with him and the agency on a host of pressing issues related to the dietary supplement industry, including a regulatory path to CBD and NAC.
“This agency has been on the front lines of the pandemic for over two years, and we salute them for their extraordinary work during this time. Nonetheless, there are still glaring deficiencies in establishing a reasonable regulatory approach for certain products like CBD and NAC that need to be addressed immediately. We look forward to working with Dr. Califf and the agency in a productive fashion to ensure consumers continue to enjoy safe and accessible natural products. Americans are turning more and more to natural products to prevent illness and support their immune systems, and we want to work together to ensure that this healthy trend continues,” said Daniel Fabricant, President and CEO of NPA.
